Prospective Single-Arm Clinical Trial of GO Regimen for HLH.

• Status: RECRUITING
• Trial end date: 2027-06-27

Summary

This study aims to investigate the efficacy and safety of Golidocitinib(GO) monotherapy in the treatment of hemophagocytic lymphohistiocytosis.

• Phase: PHASE2

Details

• Lead Sponsor: Beijing Friendship Hospital